Back to Results
First PageMeta Content
Clinical research / Pharmaceuticals policy / Drug Price Competition and Patent Term Restoration Act / Generic drug / Abbreviated New Drug Application / Food and Drug Administration / Adderall / New Drug Application / Term of patent in the United States / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry


14‐4624‐cv   State of New York v. Actavis    In the
Add to Reading List

Document Date: 2015-05-28 18:50:22

Open Document

File Size: 538,19 KB

Share Result on Facebook

City

Washington / D.C. / Katz / /

Company

BLATT / Arnold & Porter LLP / Toto / White & Case LLP / Caraco Pharm / Actavis Inc. / DeRise / Arnold & Porter / LLP / Defendant-Appellant Actavis plc / FOREST LABORATORIES LLC / DeLelle / White & Case LLP / Novo Nordisk A/S / ACTAVIS PLC / /

Event

FDA Phase / Product Issues / Product Recall / /

Facility

United States District Court / /

IndustryTerm

pharmaceutical industry / antitrust law / pharmaceutical manufacturer / treatment for Alzheimer’s disease / successive products / /

MedicalCondition

Alzheimer’s disease / moderate-to-severe Alzheimer’s disease / /

Organization

Congress / United States District Court for the Southern District of New York / U.S. Food and Drug Administration / US Federal Reserve / FDA / United States Court of Appeals For / Federal Trade Commission / /

Person

ERIC T. SCHNEIDERMAN / JOHN M. WALKER / JR. / Jessie Cheng / Robert W. Sweet / George T. Conway III / J. Mark Gidley / Eric J. Stock / Peter J. Carney / ANISHA S. DASGUPTA / Jack E. Pace III / Elinor R. Hoffmann / Barbara D. Underwood / Sarah M. Harris / Herbert Hovenkamp / Andrew Kent / Robert L. Steiner / /

Position

prescribing physician / Circuit Judge / Attorney General / Judge / Attorney General of the State of New / /

Product

Adderall XR / Namenda / Drug / State Drug / /

ProvinceOrState

District of Columbia / Florida / New York / New / Michigan / /

URL

http /

SocialTag